RSS Items

To develop and calibrate an Advanced Driver Assistance Systems (ADAS) suite

Zim Laboratories announced that it has received approval from the Central Drugs Standard Control Organization (CDSCO) for its novel fixed-dose combination (FDC) of Naproxen Delayed Release and Esomeprazole capsules (375 mg/500 mg + 20 mg/20 mg).

The allotment has been made in the ratio of 187 fully paid-up equity shares of PPL of Rs.10/- each for every 100 fully paid-up equity shares of Mangalore Chemicals & Fertilizers (MCFL) of Rs.10/- each in lieu of 3,49,91,362 equity shares of Rs.10/-

Powered by Capital Market - Live News